SCHEMBL21867107

SCHEMBL21867107

CC(C)OC(=O)c1ccc2c(c1)C(=O)N(CCCCC(=O)NS(=O)(=O)C(F)(F)F)C2=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ ALDH1A1 P00352 9/20 0.43
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA4 P22748 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ HDAC8 Q9BY41 5/20 0.42
▸ HDAC3 O15379 4/20 0.42
▸ HDAC4 P56524 4/20 0.42
▸ HDAC1 Q13547 4/20 0.42
▸ HDAC7 Q8WUI4 4/20 0.42
▸ HDAC2 Q92769 4/20 0.42
▸ HDAC10 Q969S8 4/20 0.42
▸ HDAC11 Q96DB2 4/20 0.42
▸ HDAC6 Q9UBN7 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21867298 0.88 SMN1; SMN2 (0.45) MAPTSMN1; SMN2ALDH1A1CA1CA2
SCHEMBL21867108 0.78 ALDH1A1 (0.51) MAPTALOX15CASP1CASP7HSD17B10
SCHEMBL21867106 0.76 TSHR (0.41) MAPTCA1CA2CA9HDAC8
SCHEMBL21867260 0.75 HDAC8 (0.46) SMN1; SMN2ALDH1A1HDAC8HDAC3HDAC4
SCHEMBL14587122 0.69 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1CA1CA2CA4
SCHEMBL10553025 0.68 ALDH1A1 (0.56) MAPTALOX15CASP1CASP7HSD17B10
SCHEMBL25771250 0.67 ALDH1A1 (0.62) MAPTALOX15CASP1CASP7HSD17B10
SCHEMBL9616831 0.66 SMN1; SMN2 (0.57) MAPTALOX15CASP1CASP7HSD17B10
SCHEMBL21867249 0.66 DEGS1 (0.36) MAPTHSD17B10SMN1; SMN2ALDH1A1TSHR
SCHEMBL918257 0.65 HDAC8 (0.71) SMN1; SMN2ALDH1A1HDAC8HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200115382-A1 CURABLE COMPOSITION, CURED FILM, OPTICAL FILTER, SOLID IMAGE PICKUP ELEMENT, IMAGE DISPLAY DEVICE, INFRARED SENSOR, DISPERSING AUXILIARY AGENT, DISPERSION, AND METHOD OF MANUFACTURING DISPERSION FUJIFILM CORPORATION (JP) 2020-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115382-A1 CURABLE COMPOSITION, CURED FILM, OPTICAL FILTER, SOLID IMAGE PICKUP ELEMENT, IMAGE DISPLAY DEVICE, INFRARED SENSOR, DISPERSING AUXILIARY AGENT, DISPERSION, AND METHOD OF MANUFACTURING DISPERSION PRKG2, PRKD1, PRKG1 MAPT 1675/4885ALOX15 4514/4885CASP1 4036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback